Wang, J-H and Roberts, GE and Liu, G-S, Updates on gene therapy for diabetic retinopathy, Current Diabetes Reports, 20, (7) Article 22. ISSN 1534-4827 (2020) [Refereed Article]
Copyright Springer Science+Business Media, LLC, part of Springer Nature 2020
Recent findings: Strategies for gene therapy in DR, stemming from the current understanding of the disease pathogenesis, focus on the inhibition of neovascularization and protection of neurovascular degeneration in the retina. Studies with promising results have mainly focussed on animal models due to efficacy and safety concerns, despite a number of successful preclinical studies using adeno-associated virus-mediated transduction to treat both vascular dysfunction and neuronal degeneration. With the optimization of delivery vectors, transgene regulation, and outcome measure, gene therapy will potentially become available for patients with DR.
Summary: This review provides an update on the current strategies utilized in DR gene therapy research. Several barriers to the clinical application of gene therapy for DR are highlighted, and future directions for this research are proposed.
|Item Type:||Refereed Article|
|Keywords:||angiogenesis, diabetes, gene therapy, retinopathy, diabetic retinopathy|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Medical biotechnology|
|Research Field:||Gene and molecular therapy|
|Objective Group:||Clinical health|
|Objective Field:||Clinical health not elsewhere classified|
|UTAS Author:||Liu, G-S (Associate Professor Guei-Sheung Liu)|
|Funding Support:||National Health and Medical Research Council (1185600)|
|Web of Science® Times Cited:||1|
|Deposited By:||Menzies Institute for Medical Research|
Repository Staff Only: item control page